IPO registrations (S-1, F-1) · Registrants
10x Genomics, Inc.
- SEC CIK
- 1770787 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2019-08-19, last 2020-09-08; 2 initial registrations, 2 amendments
- Outcome
- Final prospectus filed 2019-09-12; declared effective 2019-09-11
- Industry (SIC)
- Laboratory Analytical Instruments 3826
- Incorporated in
- DE
- Business address
- 6230 STONERIDGE MALL ROAD, Pleasanton, CA 94588
- EIN
- 45-5614458
- Ticker
- TXG (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- 10x Genomics, Inc. on the corporate pages
Offering terms
- Proposed price range
- $36.00–$38.00 per share (S-1/A filed 2019-09-10)
- Final price
- $39.00 per share, above the range (424B4 filed 2019-09-12, an initial public offering)
- Shares sold
- 10,000,000
- Gross proceeds
- $390,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TXG
- Lead underwriters
- J.P. Morgan; Goldman Sachs; BofA Securities
- Syndicate
- Cowen
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: 10X GENOMICS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: 10X GENOMICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: 10X GENOMICS, INC. Fuzzy (name and state)
- Form D issuer: 10X Genomics, Inc. EXACT (CIK (EXACT))
- Lobbying client: 10X GENOMICS Fuzzy (name and state)
- Lobbying client: 10X GENOMICS, INC. Fuzzy (name and state)
- SEC filer: 10x Genomics, Inc. EXACT (CIK (EXACT))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-08-19 | S-1 | S-1 (registration) | 10x Genomics, Inc. | 0001193125-19-224368 ↗ |
| 2019-09-03 | S-1/A | S-1/A (amendment) | 10x Genomics, Inc. | 0001193125-19-235727 ↗ |
| 2019-09-10 | S-1/A | S-1/A (amendment) | 10x Genomics, Inc. | 0001193125-19-241454 ↗ |
| 2019-09-11 | S-1MEF | S-1MEF (added securities) | 10x Genomics, Inc. | 0001193125-19-243228 ↗ |
| 2019-09-11 | EFFECT | EFFECT (declared effective) | 10x Genomics, Inc. | 9999999995-19-002066 ↗ |
| 2019-09-12 | 424B4 | 424B4 (final prospectus) | 10x Genomics, Inc. | 0001193125-19-243349 ↗ |
| 2020-09-08 | S-1 | S-1 (registration) | 10x Genomics, Inc. | 0001193125-20-240997 ↗ |
| 2020-09-10 | S-1MEF | S-1MEF (added securities) | 10x Genomics, Inc. | 0001193125-20-243380 ↗ |
| 2020-09-10 | EFFECT | EFFECT (declared effective) | 10x Genomics, Inc. | 9999999995-20-002417 ↗ |
| 2020-09-11 | 424B4 | 424B4 (final prospectus) | 10x Genomics, Inc. | 0001193125-20-244106 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-10 | S-1/A | registration statement | $36.00–$38.00 | 9,000,000 | - | Nasdaq TXG | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2019-09-12 | 424B4 | final prospectus | $39.00 | 10,000,000 | $390,000,000 | Nasdaq TXG | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Conley Paul A. | Director | 2 | 2019 | ||
| CRUTCHFIELD BRADFORD | Officer; Other | Chief Commercial Officer | 36 | 2019–2022 | |
| Foresite Capital Fund II, L.P. | TenPercentOwner | 8 | 2019–2020 | ||
| Foresite Capital Fund I, L.P. | TenPercentOwner | 8 | 2019–2020 | ||
| Foresite Capital Fund IV, L.P. | TenPercentOwner | 1 | 2019 | ||
| Foresite Capital Management II, LLC | TenPercentOwner | 8 | 2019–2020 | ||
| Foresite Capital Management I, LLC | TenPercentOwner | 8 | 2019–2020 | ||
| Foresite Capital Management IV, LLC | TenPercentOwner | 1 | 2019 | ||
| Hindson Benjamin J. | Director,Officer; Director,Officer,TenPercentOwner | See Remarks | 61 | 2019–2026 | |
| Kosaraju Sridhar | Director | 22 | 2019–2026 | ||
| Mammen Mathai | Director | 8 | 2019–2024 | ||
| McAnear Justin J. | Officer; Other | Chief Financial Officer | 46 | 2019–2024 | |
| ROBERTS BRYAN E | Director | 15 | 2019–2023 | ||
| Saxonov Serge | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer | 100 | 2019–2026 | |
| STUELPNAGEL JOHN R | Director | 49 | 2019–2026 | ||
| SULIMAN SHEHNAAZ | Director | 12 | 2019–2026 | ||
| Tananbaum James B. | TenPercentOwner | 8 | 2019–2020 | ||
| Venrock Associates VI, L.P. | TenPercentOwner | 6 | 2019–2020 | ||
| Venrock Management VI, LLC | TenPercentOwner | 6 | 2019–2020 | ||
| Venrock Partners Management VI, LLC | TenPercentOwner | 6 | 2019–2020 | ||
| Venrock Partners VI, L.P. | TenPercentOwner | 6 | 2019–2020 | ||
| Paladin Capital Cyber Group, LLC | TenPercentOwner | 3 | 2019–2021 | ||
| Paladin Capital Group III, LLC | TenPercentOwner | 3 | 2019–2021 | ||
| Paladin Capital Management, LLC | TenPercentOwner | 3 | 2019–2021 | ||
| Paladin Cyber Holdings, L.P. | TenPercentOwner | 3 | 2019–2021 | ||
| Paladin Holdings III (Cayman Islands), L.P. | TenPercentOwner | 3 | 2019–2021 | ||
| Paladin Holdings III, L.P. | TenPercentOwner | 3 | 2019–2021 | ||
| Paladin Homeland Security Corp III, Ltd. | TenPercentOwner | 3 | 2019–2021 | ||
| Steed Michael Robert | TenPercentOwner | 3 | 2019–2021 | ||
| SB INVESTMENT ADVISERS (UK) LTD | TenPercentOwner | 2 | 2020 | ||
| SOFTBANK VISION FUND (AIV M2) L.P. | TenPercentOwner | 2 | 2020 | ||
| Popovits Kimberly J | Director | 9 | 2020–2026 | ||
| Wilbur James | Officer | Chief Commercial Officer | 7 | 2022–2023 | |
| MATEO ALAN | Director | 5 | 2024–2026 | ||
| Teichmann Sarah A. | Director | 6 | 2024–2026 | ||
| Taich Adam | Officer | Chief Financial Officer | 10 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-05-09 | 10X Genomics, Inc. | Biotechnology | Indefinite | $0 | 0 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | 10X GENOMICS, INC. | CA | State business registries | name and state |
| Contractor | 10X GENOMICS INC | CA | Nonprofit contractors (Form 990) | name and state |
| Plan sponsor | 10X GENOMICS, INC. | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | 10X GENOMICS, INC. | CA | Federal spending (USAspending) | name and state |
| Form D issuer | 10X Genomics, Inc. | CA | Form D private offerings | CIK (EXACT) |
| IPO registrant | E LOAN INC | CA | IPO registrations (S-1, F-1) | same street address and ZIP code, 6230 STONERIDGE MALL RD 94588 (FUZZY: a shared address, not proof of a shared organization) |
| Lobbying client | 10X GENOMICS | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | 10X GENOMICS, INC. | CA | Federal lobbying (LDA) | name and state |
| Patent assignee | 10x Genomics, Inc. | CA | Patents (USPTO) | name and state |
| SEC filer | 10x Genomics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | 10X Genomics, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | 10X GENOMICS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Laboratory Analytical Instruments, CA first:
- NGEN, INC. CA
- CEPHEID CA
- LJL BIOSYSTEMS INC CA
- AGILENT TECHNOLOGIES, INC. CA
- ILLUMINA, INC. CA
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CA
- QPC Lasers CA
- WaferGen Bio-systems, Inc. CA
- PROTEINSIMPLE CA
- Bionano Genomics, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Laboratory Analytical Instruments · Technology